Litigation Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)
✉ Email this page to a colleague
CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-05-11 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Esther Salas |
| Jury Demand | None | Referred To | Michael A. Hammer |
| Parties | CELGENE CORPORATION | ||
| Patents | 10,006,091; 10,112,021; 10,555,939; 6,045,501; 6,281,230; 6,315,720; 6,476,052; 6,555,554; 6,561,976; 6,561,977; 6,755,784; 6,869,399; 7,015,018; 7,119,106; 7,141,018; 7,189,740; 7,393,862; 7,468,363; 7,959,566; 7,968,569; 8,008,006; 8,063,004; 8,198,262; 8,315,886; 8,404,717; 8,530,498; 8,626,531; 8,648,095; 8,673,939; 8,735,428; 8,828,427; 8,927,592; 9,024,096; 9,028,005; 9,056,120; 9,101,621; 9,101,622; 9,109,020; 9,993,467 | ||
| Attorneys | MONVAN HU | ||
| Firms | Saul Ewing Arnstein & Lehr LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in CELGENE CORPORATION v. HETERO LABS LIMITED
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for CELGENE CORPORATION v. HETERO LABS LIMITED (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | 168 | Letter | judgment of non-infringement of U.S. Patent No. 8,828,427 B2 (“’427 patent”). At the …judgment of non-infringement of U.S. Patent No. 8,828,427 (“’427 patent”); WHEREAS, on May 11…summary judgment of non-infringement of the ’427 patent (“Joint Letter concerning summary judgment…5 PageID: 4303 non-infringement of the ’427 patent by May 25, 2018 (17-3159 ECF No. 89, Text Order…summary judgment of non-infringement of the ’427 patent, and wish to join in the joint letter to be submitted | External link to document |
| 2018-06-04 | 171 | antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ … United States Patent (10) Patent No.: … (45) Date of Patent: Sep.9,2014 (54)… U.S. PATENT DOCUMENTS Hopatcong, OH … FOREIGN PATENT DOCUMENTS ( *) Notice: Subject to | External link to document | |
| 2018-08-29 | 211 | Statement | Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of United States Patent No. 6,045,501 …Evidence: • U.S. Patent No. 6,045,501 generally, including … • File History of U.S. Patent No. 6,045,501 at o Claims, Abstract, … • U.S. Patent No. 6,045,501: | External link to document |
| 2018-10-05 | 227 | Exhibits 1-15 (Part 1) | antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/ …Claims of U.S. Patent Nos. 8,198,262 (“the ’262 patent”), 8,673,939 (“the ’939 patent”), 8,735,428 …8,735,428 (“the ’428 patent”), and 8,828,427 (“the ’427 patent”) (collectively, “the Patents-in-Suit”). …clients. One of the patents 3 is a formulation patent. It's a very specific…): Patent Asserted Claims ’262 patent [DEFS_POM_ | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
